Literature DB >> 21320124

Regulation of effector and memory T-cell functions by type I interferon.

Jonathan P Huber1, J David Farrar.   

Abstract

Type I interferon (IFN-α/β) is comprised of a family of highly related molecules that exert potent antiviral activity by interfering with virus replication and spread. IFN-α/β secretion is tightly regulated through pathogen sensing pathways that are operative in most somatic cells. However, specialized antigen-presenting plasmacytoid dendritic cells are uniquely equipped with the capacity to secrete extremely high levels of IFN-α/β, suggesting a key role for this cytokine in priming adaptive T-cell responses. Recent studies in both mice and humans have demonstrated a role for IFN-α/β in directly influencing the fate of both CD4(+) and CD8(+) T cells during the initial phases of antigen recognition. As such, IFN-α/β, among other innate cytokines, is considered an important 'third signal' that shapes the effector and memory T-cell pool. Moreover, IFN-α/β also serves as a counter-regulator of T helper type 2 and type 17 responses, which may be important in the treatment of atopy and autoimmunity, and in the development of novel vaccine adjuvants.
© 2011 The Authors. Immunology © 2011 Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21320124      PMCID: PMC3075500          DOI: 10.1111/j.1365-2567.2011.03412.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  104 in total

Review 1.  Developmental plasticity of Th17 and Treg cells.

Authors:  Yun Kyung Lee; Ryuta Mukasa; Robin D Hatton; Casey T Weaver
Journal:  Curr Opin Immunol       Date:  2009-06-11       Impact factor: 7.486

2.  Blockade of virus infection by human CD4+ T cells via a cytokine relay network.

Authors:  Ann M Davis; Kristan A Hagan; Loderick A Matthews; Gagan Bajwa; Michelle A Gill; Michael Gale; J David Farrar
Journal:  J Immunol       Date:  2008-05-15       Impact factor: 5.422

3.  Programming for CD8 T cell memory development requires IL-12 or type I IFN.

Authors:  Zhengguo Xiao; Kerry A Casey; Stephen C Jameson; Julie M Curtsinger; Matthew F Mescher
Journal:  J Immunol       Date:  2009-03-01       Impact factor: 5.422

4.  Reciprocal responsiveness to interleukin-12 and interferon-alpha specifies human CD8+ effector versus central memory T-cell fates.

Authors:  Hilario J Ramos; Ann M Davis; Alexander G Cole; John D Schatzle; James Forman; J David Farrar
Journal:  Blood       Date:  2009-03-18       Impact factor: 22.113

5.  Signal transducer and activator of transcription 4 is required for the transcription factor T-bet to promote T helper 1 cell-fate determination.

Authors:  Vivian T Thieu; Qing Yu; Hua-Chen Chang; Norman Yeh; Evelyn T Nguyen; Sarita Sehra; Mark H Kaplan
Journal:  Immunity       Date:  2008-11-14       Impact factor: 31.745

6.  Cutting edge: a T-bet-independent role for IFN-alpha/beta in regulating IL-2 secretion in human CD4+ central memory T cells.

Authors:  Ann M Davis; Hilario J Ramos; Laurie S Davis; J David Farrar
Journal:  J Immunol       Date:  2008-12-15       Impact factor: 5.422

7.  Effects of Signal 3 during CD8 T cell priming: Bystander production of IL-12 enhances effector T cell expansion but promotes terminal differentiation.

Authors:  Weiguo Cui; Nikhil S Joshi; Aimin Jiang; Susan M Kaech
Journal:  Vaccine       Date:  2009-02-06       Impact factor: 3.641

8.  Interferon-alpha controls IL-17 expression in vitro and in vivo.

Authors:  Alexander R Moschen; Sabine Geiger; Ingomar Krehan; Arthur Kaser; Herbert Tilg
Journal:  Immunobiology       Date:  2008-08-30       Impact factor: 3.144

Review 9.  Update on inflammation, neurodegeneration, and immunoregulation in multiple sclerosis: therapeutic implications.

Authors:  Jeffrey L Bennett; Olaf Stüve
Journal:  Clin Neuropharmacol       Date:  2009 May-Jun       Impact factor: 1.592

10.  IFN-lambda1 (IL-29) inhibits GATA3 expression and suppresses Th2 responses in human naive and memory T cells.

Authors:  Jihong Dai; Nicholas J Megjugorac; Grant E Gallagher; Raymond Y L Yu; Grant Gallagher
Journal:  Blood       Date:  2009-04-03       Impact factor: 22.113

View more
  109 in total

1.  Superior induction of T cell responses to conserved HIV-1 regions by electroporated alphavirus replicon DNA compared to that with conventional plasmid DNA vaccine.

Authors:  Maria L Knudsen; Alice Mbewe-Mvula; Maximillian Rosario; Daniel X Johansson; Maria Kakoulidou; Anne Bridgeman; Arturo Reyes-Sandoval; Alfredo Nicosia; Karl Ljungberg; Tomás Hanke; Peter Liljeström
Journal:  J Virol       Date:  2012-02-08       Impact factor: 5.103

2.  The presence of alpha interferon at the time of infection alters the innate and adaptive immune responses to porcine reproductive and respiratory syndrome virus.

Authors:  Susan L Brockmeier; Crystal L Loving; Eric A Nelson; Laura C Miller; Tracy L Nicholson; Karen B Register; Marvin J Grubman; Douglas E Brough; Marcus E Kehrli
Journal:  Clin Vaccine Immunol       Date:  2012-02-01

3.  Putting the brakes on ILC2 cells.

Authors:  Christina Stehle; Philippe Saikali; Chiara Romagnani
Journal:  Nat Immunol       Date:  2016-01       Impact factor: 25.606

4.  Identifying a role for Toll-like receptor 3 in the innate immune response to Chlamydia muridarum infection in murine oviduct epithelial cells.

Authors:  Wilbert A Derbigny; LaTasha R Shobe; Jasmine C Kamran; Katherine S Toomey; Susan Ofner
Journal:  Infect Immun       Date:  2011-10-17       Impact factor: 3.441

5.  Nanoparticle conjugation of CpG enhances adjuvancy for cellular immunity and memory recall at low dose.

Authors:  Alexandre de Titta; Marie Ballester; Ziad Julier; Chiara Nembrini; Laura Jeanbart; André J van der Vlies; Melody A Swartz; Jeffrey A Hubbell
Journal:  Proc Natl Acad Sci U S A       Date:  2013-11-18       Impact factor: 11.205

6.  Mucosal polyinosinic-polycytidylic acid improves protection elicited by replicating influenza vaccines via enhanced dendritic cell function and T cell immunity.

Authors:  José V Pérez-Girón; Alan Belicha-Villanueva; Ebrahim Hassan; Sergio Gómez-Medina; Jazmina L G Cruz; Anja Lüdtke; Paula Ruibal; Randy A Albrecht; Adolfo García-Sastre; César Muñoz-Fontela
Journal:  J Immunol       Date:  2014-06-23       Impact factor: 5.422

7.  IL-12 selectively programs effector pathways that are stably expressed in human CD8+ effector memory T cells in vivo.

Authors:  Fatema Z Chowdhury; Hilario J Ramos; Laurie S Davis; James Forman; J David Farrar
Journal:  Blood       Date:  2011-08-10       Impact factor: 22.113

Review 8.  Immune responses and immunotherapeutic interventions in malignant pleural mesothelioma.

Authors:  Adam J Bograd; Kei Suzuki; Eva Vertes; Christos Colovos; Eduardo A Morales; Michel Sadelain; Prasad S Adusumilli
Journal:  Cancer Immunol Immunother       Date:  2011-09-13       Impact factor: 6.968

9.  A Rhesus Rhadinovirus Viral Interferon (IFN) Regulatory Factor Is Virion Associated and Inhibits the Early IFN Antiviral Response.

Authors:  Gabriela Morin; Bridget A Robinson; Kelsey S Rogers; Scott W Wong
Journal:  J Virol       Date:  2015-05-13       Impact factor: 5.103

Review 10.  Constitutive type I interferon modulates homeostatic balance through tonic signaling.

Authors:  Daniel J Gough; Nicole L Messina; Christopher J P Clarke; Ricky W Johnstone; David E Levy
Journal:  Immunity       Date:  2012-02-24       Impact factor: 31.745

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.